|
ANKRA2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.59240000002981E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.592560E-04 |
| Normal-vs-Stage2 |
6.24919999999696E-05 |
| Normal-vs-Stage3 |
3.92930000000513E-05 |
| Normal-vs-Stage4 |
2.416900E-04 |
| Stage1-vs-Stage2 |
7.172100E-02 |
| Stage1-vs-Stage3 |
2.048200E-01 |
| Stage1-vs-Stage4 |
2.550200E-01 |
| Stage2-vs-Stage3 |
4.345600E-01 |
| Stage2-vs-Stage4 |
5.764600E-01 |
| Stage3-vs-Stage4 |
8.764000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.76770000001903E-06 |
| Normal-vs-AfricanAmerican |
8.724200E-02 |
| Normal-vs-Asian |
7.143800E-03 |
| Caucasian-vs-AfricanAmerican |
2.571000E-01 |
| Caucasian-vs-Asian |
4.552200E-01 |
| AfricanAmerican-vs-Asian |
6.106600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.971590E-04 |
| Normal-vs-Female |
4.68180000001706E-06 |
| Male-vs-Female |
6.528800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.842300E-04 |
| Normal-vs-Age(41-60Yrs) |
6.30149999999441E-05 |
| Normal-vs-Age(61-80Yrs) |
2.25419999999588E-05 |
| Normal-vs-Age(81-100Yrs) |
1.188030E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.528000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.526580E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.649000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.485200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.711800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.939600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.248360E-01 |
| Classical-VS-Follicular |
2.243400E-01 |
| Classical-VS-Other |
7.566600E-01 |
| Classical-VS-Normal |
1.194110E-04 |
| Tall-VS-Follicular |
5.887200E-01 |
| Tall-VS-Other |
6.410600E-01 |
| Tall-VS-Normal |
1.391310E-04 |
| Follicular-VS-Other |
8.918800E-01 |
| Follicular-VS-Normal |
3.982500E-04 |
| Other-VS-Normal |
1.204040E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.84089999996939E-06 |
| Normal-vs-N1 |
1.155610E-02 |
| N0-vs-N1 |
3.235000E-01 |
|
|
